BN(BN)

Overview Intelligence Chart Fundamentals Key Metrics Earnings Growth Analysts Financials Insiders Institutional

Next earnings: Aug 6, 2026 · Before open

Signal

Mixed1↑1↓

Price

1↓

Move↓-4.19%Selling pressure

Volume

1→

Volume→0.9× avgNormal activity

Technical

1↑

RSI↑RSI 51Momentum positive

PRICE

Prev Close

47.53

Open

46.64

Day Range45.41 – 46.85

45.41

46.85

52W Range37.54 – 49.57

37.54

49.57

67% of range

VOLUME & SIZE

Avg Volume

6.2M

FUNDAMENTALS

P/E Ratio

89.3x

Premium valuation

EPS (TTM)

—

Div Yield

No dividend

Performance

-4.19%

-2.78%

-0.89%

3M↓

-4.69%

+3.38%

YTD

-0.76%

1Y↑

+14.34%

Best: 1Y (+14.34%)Worst: 3M (-4.69%)

Quick Read

Trend—Insufficient MA data

Momentum

BEARISH

revenue -6% YoY

Valuation

EXPENSIVE

P/E 89x vs ~20x sector

Health

WEAK

CR 1.7 · FCF negative

Trend

Momentum

Valuation

Health

Bearish

Composite signal across trend, momentum, valuation & healthSignals from latest available data

Key MetricsTTM

Market Cap$101.88B

Revenue TTM$76.58B

Net Income TTM$1.33B

Free Cash Flow-$7.27B

Gross Margin35.3%

Net Margin1.7%

Operating Margin28.3%

Return on Equity2.8%

Return on Assets0.3%

Debt / Equity5.72

Current Ratio1.72

EPS TTM$0.53

Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar

1 watch5 concern

17/100

Liquidity

1.72Watch

Leverage

5.72Concern

Coverage

1.3xConcern

ROE

2.8%Concern

ROIC

3.2%Concern

Cash

$16.2BConcern

ANALYST COVERAGE9 analysts

BUY

▲ +25.2%upside to target

L $49.00

Med $57.00consensus

H $61.00

Buy

889%

Hold

111%

8 Buy (89%)1 Hold (11%)0 Sell (0%)

Full report →

Stock Health

Composite Score

3 of 5 signals bullish

7/10

Technicals

●

RSI RangeRSI 51 — Bullish momentum

✓

Volume

●

Volume FlowNeutral

Fundamentals

●

Last EarningsMissed estimates

✗

●

Analyst ConsensusBuy

✓

●

LiquidityCurrent Ratio 1.72 — healthy liquidity

✓

Upcoming Events

EEarnings ReportMay 18, 2026

Tomorrow

DEx-Dividend DateAug 14, 2026

In 89 days

PDividend PaymentAug 31, 2026

In 106 days

Research

Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→

FinancialsFull statements →

Technicals

Technical SetupBULLISH

Technicals →

Trend

▲ UptrendDeath Cross · 50D trails 200D by 4.4%

+6.2% vs SMA 50 · +1.5% vs SMA 200

Momentum

RSI50.7

Neutral territory

MACD+0.73

Above zero — bullish momentum · compressing

Market Position

Price Levels

52W High

$49.57+8.8%

Current

$45.54

EMA 50

$44.55-2.2%

EMA 200

$43.99-3.4%

52W Low

$37.54-17.6%

52-Week RangeMid-range

$37.5467th %ile$49.57

Squeeze SetupVolume-based

No Clear Setup

Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.

20-Day Money Flow

Acc days:3

Dist days:2

Edge:+1 acc

Volume Context

Avg Vol (50D)6.1M

Recent Vol (5D)

6.4M+6%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 3 analysts

Full estimates →

Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

Year	Revenue Est.	Rev Gth	EPS Est.	EPS Gth	Range	Analysts
FY2023	$4.5B $4.1B–$4.8B	—	$1.91	—	±11%	Moderate3
FY2024	$5.5B $5.4B–$5.5B	▲ +22.9%	$2.39	▲ +25.1%	±1%	Low1
FY2025	$8.2B $8.1B–$8.2B	▲ +49.5%	$2.43	▲ +1.6%	±1%	Low2

Range confidence:Tight (high)ModerateWide (low)

Earnings HistoryBN

Last 8Q

+15.3%avg beat

Beat 6 of 8 quartersMissed 2↑ Estimates rising

+76%

Q3'24

+1%

Q4'24

+18%

Q1'25

+15%

Q2'25

-1%

Q3'25

+6%

Q4'25

+10%

Q1'26

-3%

Q2'26

Beat

Miss

Estimate

Deeper color = bigger beat/miss

Analyst Activity

All ratings →

No recent activity

Credit SuisseNeutral → Outperform

Mar 20

UPGRADE

Credit SuisseNeutral

Feb 6

DOWNGRADE

Empire Asset Manage…Neutral

Apr 27

UPGRADE

Insider Activity

SEC Filings →

0 Buys/6 SellsNet Selling

Bcp Gp Ltd10%

$2.3M

Jan 2

SELL

Bcp Gp Ltd10%

$2.3M

Jan 2

SELL

Bcp Gp Ltd10%

$4.1M

Jan 2

SELL

Bcp Gp Ltd10%

$194

Jan 2

SELL

Bcp Gp Ltd10%

$150

Jan 2

SELL

Bcp Gp Ltd10 Percent Own…

$226K

Dec 28

SELL

Financials

Dividends0.55% yield

3 yrs of payments

Annual Yield0.55%

Quarterly Div.$0.0700

Est. Annual / Share$0.28

FrequencyQuarterly

Q3'24

Q4'24

Q1'25

Q2'25

Q3'25

Q4'25

Q1'26

Q2'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

13-F Filings →

Partners Value Investments LP

181.4M—

ROYAL BANK OF CANADA

113.8M▲

Capital World Investors

82.3M▼

PRINCIPAL FINANCIAL GROUP INC

63.8M▼

Pershing Square Capital Management, L.P.

59.7M▼

DODGE & COX

59.2M▲

BANK OF MONTREAL /CAN/

54.8M▼

BROOKFIELD Corp /ON/

46.6M—

News & Activity

BN News

About

No company information available

Peers— —(7 companies)

Screen sector →

Symbol	Name	Price	Day %	Mkt Cap↓	P/E	Rev Grw	Margin	ELO
BN◀	Brookfield Corpora…	$45.54	-4.19%	$101.9B	85.4	-1148.5%	171.7%	1500
TSM	Taiwan Semiconduct…	$404.35	-3.20%	$2.1T	30.5	+3296.8%	4510.0%	1500
BABA	Alibaba Group Hold…	$132.58	-6.05%	$307.9B	20.7	-44.8%	1012.0%	1500
HSBC	HSBC Holdings	$88.38	-2.58%	$303.7B	13.6	+318.8%	1510.7%	1500
NVS	Novartis AG Common…	$148.08	-1.13%	$282.6B	21.0	+597.3%	2564.4%	1500
AZN	AstraZeneca PLC Or…	$181.58	-1.83%	$281.6B	26.9	+862.9%	1745.9%	1500
RY	Royal Bank Of Cana…	$183.40	-0.23%	$256.1B	16.8	+213.3%	1482.4%	1500
Sector avg		—	-2.74%	—	30.7	+585.1%	1856.7%	1500

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance